<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Loscalzo, Joseph</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Personalized Cardiovascular Medicine and Drug Development - Time for a New Paradigm</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">8-9</style></pages><abstract><style  face="normal" font="default" size="100%">Each year, the American Heart Association presents the Lewis A. Conner Memorial Lecture to honor the memory of one of the founders of the AHA. This year, Joseph Loscalzo, MD, PhD, FAHA, Harvard Medical School, Boston, Massachusetts, USA, delivered a presentation on the potential for a more personal, systems- and network-based approach to drug development.</style></abstract><number><style face="normal" font="default" size="100%">15</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>